Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-08-13
2023-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immobilization control
The immobilization control group will undergo arm immobilization. Immobilization will be implemented with four weeks of muscle unloading with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body.
Orthopedic immobilization
Orthopedic immobilization will be performed with a sling and swathe.
Bilateral resistance training
Bilateral resistance training will be performed by both arms in both groups during Phase 2.
Immobilization with unilateral training
The immobilization with unilateral training group will undergo arm immobilization for four with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body. The free (non-immobilzed) arm of this group will undergo heavy strength training twice per week throughout the immobilization period. The training will consist of unilateral dumbbell shoulder press and biceps curl.
Orthopedic immobilization
Orthopedic immobilization will be performed with a sling and swathe.
Unilateral resistance training
Unilateral resistance training will be performed by the dominant arm of the immobilization + unilateral resistance training group during Phase 1.
Bilateral resistance training
Bilateral resistance training will be performed by both arms in both groups during Phase 2.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Orthopedic immobilization
Orthopedic immobilization will be performed with a sling and swathe.
Unilateral resistance training
Unilateral resistance training will be performed by the dominant arm of the immobilization + unilateral resistance training group during Phase 1.
Bilateral resistance training
Bilateral resistance training will be performed by both arms in both groups during Phase 2.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-35 years of age
* right-hand dominant
* willingness to comply with the immobilization requirements
* willingness to refrain from strength training outside of the study
* willingness to comply with the strength training procedures of the study
Exclusion Criteria
* a personal or family history of thyroid disorders
* previous orthopedic surgeries to the upper limbs and/or joint pain of the upper limbs in the last 6 months
* neuromuscular or metabolic disorders
* osteoarthritis
* use of hormone replacement therapy (ie., testosterone, estrogen, and/or growth hormone pharmaceuticals)
* pregnancy and/or nursing
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas Christian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joshua Carr
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TCU Neuromuscular Physiology Laboratory
Fort Worth, Texas, United States
TCU RIC
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joshua C Carr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-101
Identifier Type: -
Identifier Source: org_study_id